Mindray Medical (MR) Growth Potential Offsets Negatives, Jefferies Reiterates Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Mindray Medical (MR) Growth Potential Offsets Negatives, Jefferies Reiterates Buy

Mindray Medical International (MR) Tops Q3 EPS by 1c; Guides FY12 EPS Growth

November 5, 2012 5:01 PM EST

Mindray Medical International (NYSE: MR) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $257.1 million versus the consensus estimate of $260.02 million.

Mindray expects its full-year 2012 non-GAAP net income to grow at least 15% over last year's... More